Organization Name Bluebird BioAnnounced Date Apr 20, 2011 Funding Type Series C Funding Stage Late Stage Venture Money Raised
- ARCH Venture Partners
ARCH is a venture firm that focuses on life science discoveries to prevent, detect, and cure disease.
TVM Capital Life Science Venture Capital — bluebird bio Secures Additional $30 Million in Financing
FinSMEs — bluebird bio Raises $30M